# A Protocol of Irinotecan for Carcinoma of the Lung

> **NCT01654081** · PHASE2 · WITHDRAWN · sponsor: **Susanne Arnold**

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT01654081
- **Lead sponsor:** Susanne Arnold
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-10
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2014-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01654081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01654081, "A Protocol of Irinotecan for Carcinoma of the Lung". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01654081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*